Lam Research Corporation $LRCX Shares Acquired by AQR Capital Management LLC

Key Points

• AQR Capital Management LLC significantly increased its stake in Lam Research Corporation by 63.5%, owning approximately 907,326 shares valued at $64.5 million.
• Lam Research reported a strong quarterly earnings performance, with $1.33 earnings per share, surpassing analysts' estimates and achieving a revenue of $5.17 billion.
• The company announced a dividend increase, with a quarterly payment of $0.26 per share, up from the previous $0.23, reflecting a solid dividend yield of 1.0%.

AQR Capital Management LLC grew its stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 63.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 907,326 shares of the semiconductor company's stock after buying an additional 352,264 shares during the period. AQR Capital Management LLC owned 0.07% of Lam Research worth $64,520,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Advisors Asset Management Inc. grew its holdings in shares of Lam Research by 40.1% in the first quarter. Advisors Asset Management Inc. now owns 64,870 shares of the semiconductor company's stock valued at $4,716,000 after purchasing an additional 18,566 shares in the last quarter. American Trust Investment Advisors LLC raised its holdings in shares of Lam Research by 1.7% in the first quarter. American Trust Investment Advisors LLC now owns 57,997 shares of the semiconductor company's stock valued at $4,216,000 after acquiring an additional 970 shares in the last quarter. 1 North Wealth Services LLC purchased a new stake in shares of Lam Research in the 1st quarter worth approximately $36,000. Adage Capital Partners GP L.L.C. increased its holdings in shares of Lam Research by 2.2% in the 1st quarter. Adage Capital Partners GP L.L.C. now owns 1,412,020 shares of the semiconductor company's stock valued at $102,654,000 after acquiring an additional 30,900 shares during the period. Finally, Alkeon Capital Management LLC raised its stake in shares of Lam Research by 23.2% during the 1st quarter. Alkeon Capital Management LLC now owns 7,954,456 shares of the semiconductor company's stock worth $578,289,000 after acquiring an additional 1,495,736 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company's stock.

Analyst Ratings Changes

LRCX has been the subject of a number of research analyst reports. Argus raised their price target on shares of Lam Research from $105.00 to $120.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Mizuho boosted their price objective on Lam Research from $115.00 to $120.00 and gave the stock an "outperform" rating in a research note on Friday, August 1st. Morgan Stanley reiterated an "underweight" rating and set a $92.00 price objective (down previously from $94.00) on shares of Lam Research in a research report on Tuesday, September 2nd. Raymond James Financial raised their price objective on Lam Research from $90.00 to $110.00 and gave the stock an "outperform" rating in a research report on Thursday, July 31st. Finally, UBS Group boosted their price target on shares of Lam Research from $95.00 to $120.00 and gave the stock a "buy" rating in a research note on Monday, July 21st. Twenty analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Lam Research presently has a consensus rating of "Moderate Buy" and a consensus target price of $107.52.

Lam Research Price Performance

Shares of NASDAQ LRCX traded up $8.22 during trading on Thursday, hitting $115.58. 20,287,639 shares of the company were exchanged, compared to its average volume of 10,496,659. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $115.90. The company has a market cap of $146.28 billion, a price-to-earnings ratio of 27.78, a PEG ratio of 1.38 and a beta of 1.76. The firm's fifty day moving average price is $100.71 and its 200 day moving average price is $86.43.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.21 by $0.12. The company had revenue of $5.17 billion during the quarter, compared to analysts' expectations of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. During the same period last year, the company posted $1.03 earnings per share. The firm's quarterly revenue was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, sell-side analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th will be given a $0.26 dividend. This is an increase from Lam Research's previous quarterly dividend of $0.23. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Wednesday, September 24th. Lam Research's dividend payout ratio (DPR) is 25.00%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.